Dr. Chelcie Heaney has strong behavioral and molecular neuroscience expertise, including preclinical animal models and mechanisms affecting molecular translation. Her previous research included elucidating the role of inhibitory signaling in learning and memory processes, identifying the key molecular mechanisms associated with the efficacy of rapid antidepressants, utilizing bioinformatics to identify FDA-approved medicines predicted to treat major depression in autism, and examining how major depressive disorder and alcohol use disorders co-occur, with an emphasis on adolescent vulnerability. Dr. Heaney’s work has been supported by various funding sources, including a Graduate Student Scholarship from the American Psychological Foundation and Council of Graduate Departments of Psychology, a National Institutes of Health (NIH) T32 Training Grant from Wake Forest University School of Medicine’s Department of Neuroscience, and a Postdoctoral Fellowship from the Fragile X Research Foundation. At EGC, Dr. Heaney enjoys collaborating with scientists with diverse training backgrounds, and helping clients obtain funding to develop their groundbreaking technologies. In her free time, Dr. Heaney enjoys cooking and baking, solving cryptic crosswords, and exploring the culinary offerings of the cities around her.
Eva Garland Consulting (EGC) was established by Dr. Eva Garland in 2013 with a mission to advance science. Over the past decade, EGC has emerged as a global leader in securing non-dilutive funding and providing comprehensive accounting and compliance services.
EGC has successfully assisted clients in securing and managing hundreds of grants and contracts, totaling over $2 billion. The firm has been honored by Inc. 5000 as one of the fastest-growing companies in the nation for six consecutive years, a distinction achieved by fewer than 1 in 10,000,000 companies.
EGC’s 3,000+ clients from 50 states and 5 continents include universities, startups, big pharma, and government agencies. EGC is proud to have supported our clients in progressing technologies from concept to commercialization, contributing new tools to tackle some of the world’s most pressing challenges.
Do you have a great company in the bioscience or medtech industry? Do you need wet-lab and/or fabrication space to develop and test your product?
